# Glenmark Pharmaceuticals Limited, Solan, India – FDA Inspections

Source: https://www.keypedia.com/companies/glenmark-pharmaceuticals-limited/66c964bb-f670-493b-ab86-aa8507e68a5d

> Inspection records and compliance data for Glenmark Pharmaceuticals Limited in Solan. 8 FDA inspections on record (1 OAI), 2 Form 483s, 2 warning letters, last inspected June 22, 2022.

---

## Details

- Name: Glenmark Pharmaceuticals Limited
- FEI Number: 3005757050
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK
- Address Line 1: Village Kishanpura, Baddi Nalagarh Road, Baddi
- City: Solan
- Country Name: India
- Address: Village Kishanpura, Baddi Nalagarh Road, Baddi, Solan, India
- Country: India

## Related Documents

- [483 - Glenmark Pharmaceuticals Limited - 2022-06-22](https://www.keypedia.com/records/483/glenmark-pharmaceuticals-limited/bbfcf848-0ee0-45ac-a30f-6b77a402de44) — source: FDA, date: June 22, 2022
- [FDA Inspection 1172425 - Glenmark Pharmaceuticals Limited - 2022-06-22](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/84dfdb76-1ec3-4ae9-a550-4882585f55ac) — classification: Official Action Indicated (OAI), source: FDA, date: June 22, 2022
- [WARNING_LETTER - Glenmark Pharmaceuticals Limited - 2022-05-20](https://www.keypedia.com/records/warning_letter/glenmark-pharmaceuticals-limited/0ac1907c-5a77-4f23-8229-957f8b7079ca) — source: FDA, date: May 20, 2022
- [483 - Glenmark Pharmaceuticals Limited - 2019-04-20](https://www.keypedia.com/records/483/glenmark-pharmaceuticals-limited/b7ff58c7-f479-4ebb-a95a-ce9b1c103a62) — source: FDA, date: April 20, 2019
- [WARNING_LETTER - Glenmark Pharmaceuticals Limited - 2019-04-20](https://www.keypedia.com/records/warning_letter/glenmark-pharmaceuticals-limited/564e19c0-f3be-4691-97d4-7b89ca5fceb2) — source: FDA, date: April 20, 2019
- [FDA Inspection 1087639 - Glenmark Pharmaceuticals Limited - 2019-04-20](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/3d480abd-bd12-4e91-b835-c48415d17346) — source: FDA, date: April 20, 2019
- FDA Inspection 1070594 - Glenmark Pharmaceuticals Limited - 2018-09-21 — classification: No Action Indicated (NAI), source: FDA, date: September 21, 2018
- [483 - Glenmark Pharmaceuticals Limited - 2017-11-11](https://www.keypedia.com/records/483/glenmark-pharmaceuticals-limited/da1521e9-2291-4a93-9ea2-3fdff9b7facf) — source: FDA, date: November 11, 2017
- [FDA Inspection 1031652 - Glenmark Pharmaceuticals Limited - 2017-11-11](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/9dbf23a8-439d-4a57-bd29-3319b9215d79) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 11, 2017
- FDA Inspection 1012923 - Glenmark Pharmaceuticals Limited - 2017-04-19 — source: FDA, date: April 19, 2017
- [FDA Inspection 929619 - Glenmark Pharmaceuticals Limited - 2015-05-29](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/e5a82147-ec6f-492c-83d4-281cf15f8b12) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 29, 2015
- FDA Inspection 802324 - Glenmark Pharmaceuticals Limited - 2012-08-24 — classification: No Action Indicated (NAI), source: FDA, date: August 24, 2012
- FDA Inspection 643147 - Glenmark Pharmaceuticals Limited - 2009-11-13 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 13, 2009

## Related Companies

- [NATCO Pharma Limited](https://www.keypedia.com/companies/natco-pharma-limited/4c97e2d8-0023-4572-966f-d396e8fecc05)
- [Pfizer Healthcare India Private Limited](https://www.keypedia.com/companies/pfizer-healthcare-india-private-limited/50c6f34f-3ef8-4cd6-bd55-6e1ee280d4f7)
- [Ascent Pharmaceuticals Inc](https://www.keypedia.com/companies/ascent-pharmaceuticals-inc/a6df28ee-9e4e-4fae-8eed-dbe5eb870593)
- [Ipca Laboratories Limited](https://www.keypedia.com/companies/ipca-laboratories-limited/4221e8f5-a261-45fc-b9fc-d935bc1f225b)
- [Mylan Laboratories Limited](https://www.keypedia.com/companies/mylan-laboratories-limited/4fd10a2e-3696-4bd0-82aa-e875143028c0)
- [Cipla Limited](https://www.keypedia.com/companies/cipla-limited/de9dc5de-fbea-4a7d-ab5b-a398b6ed442e)
- [GRANULES LIFE SCIENCES PRIVATE LIMITED](https://www.keypedia.com/companies/granules-life-sciences-private-limited/434955b0-03c5-4fc0-a6c2-1241872c2974)
- [Aarkish Pharmaceuticals NJ Inc](https://www.keypedia.com/companies/aarkish-pharmaceuticals-nj-inc/62c50ef6-4542-4051-b9f0-04ba004fb177)
- [Modavar Pharmaceuticals](https://www.keypedia.com/companies/modavar-pharmaceuticals/9b63702d-7db4-4738-8b79-5f7fc9cd73d6)
- [Procter & Gamble Manufactura S. de R.L. de C.V.](https://www.keypedia.com/companies/procter-gamble-manufactura-s-de-rl-de-cv/8b78eeab-6efe-4a8d-b98a-c1bfda966646)

## Related Officers

- [Jogy George](https://www.keypedia.com/people/jogy-george/00ef0915-66d2-4b34-9b74-d1e08caf2db3)
- [Dipesh K. Shah](https://www.keypedia.com/people/dipesh-k-shah/d4df4040-13d1-477b-8c21-4c8e5b3fc5b9)
- [Rita Kabaso](https://www.keypedia.com/people/rita-kabaso/a8383d6d-b945-4edc-97a4-90944574835d)
- [Doug Cadre](https://www.keypedia.com/people/doug-cadre/b555b16a-58e5-435c-9a46-352863b57a8c)
- [Director](https://www.keypedia.com/people/francis-godwin/1556d203-d47c-4744-af37-2591a163149e)
